Bioretec was allowed a U.S. patent for its RemeOs magnesium alloy composition.
The allowed patent concerns RemeOs’ magnesium-calcium-zinc alloy composition for orthopedic implants. It also includes the usage of RemeOs magnesium alloy in manufacturing orthopedic implants or a part of such implants for all patient populations.
The patented magnesium alloy material is used in Bioretec’s RemeOs trauma screws and forthcoming pipeline products.
Bioretec is now moving forward with the application process for this allowed patent to an international PCT application covering regions outside of the United States.
“The allowance of this patent for RemeOs biodegradable metal composition in the U.S., which is our main target market, is an integral part of our IPR strategy and protection of RemeOs technology,” said Timo Lehtonen, CEO.
Bioretec was allowed a U.S. patent for its RemeOs magnesium alloy composition.
The allowed patent concerns RemeOs’ magnesium-calcium-zinc alloy composition for orthopedic implants. It also includes the usage of RemeOs magnesium alloy in manufacturing orthopedic implants or a part of such implants for all patient populations.
The patented...
Bioretec was allowed a U.S. patent for its RemeOs magnesium alloy composition.
The allowed patent concerns RemeOs’ magnesium-calcium-zinc alloy composition for orthopedic implants. It also includes the usage of RemeOs magnesium alloy in manufacturing orthopedic implants or a part of such implants for all patient populations.
The patented magnesium alloy material is used in Bioretec’s RemeOs trauma screws and forthcoming pipeline products.
Bioretec is now moving forward with the application process for this allowed patent to an international PCT application covering regions outside of the United States.
“The allowance of this patent for RemeOs biodegradable metal composition in the U.S., which is our main target market, is an integral part of our IPR strategy and protection of RemeOs technology,” said Timo Lehtonen, CEO.
Copy to clipboard 
